Coral Springs, FL

Advanced Research, LLC

Cancer

Crohn Disease

Pertuzumab

Ritonavir

Itraconazole

Filgotinib

DualityBio

Galapagos

condition

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

This is a dose-escalation and dose-expansion Phase 1/2a trial to evaluate the safety and tolerability of DB-1303/BNT323 in subjects with advanced solid tumors that express HER2.

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Advanced Research, LLC | Coral Springs, FL

Site insights

Work at this site?

Active trials

A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors

Trial sponsors